Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Nordson Corporation (NDSN) SEC Filings & Earnings Calls

EquiReason read 13 Nordson Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-10-23 — Nordson completed acquisition of Contrinex for ~$168M enterprise value, expanding industrial sensing and automation portfolio. Contrinex generates ~$50M annual revenue. Acquisition.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

NDSNNordson CorporationFollow NDSN — free
Specialty Industrial Machinery · Industrials
—
Price chart with a free account
Market cap
17.8B
P/E TTM
32.3
Dividend yield
1.0%
52-week
—
Next earnings
8 Dec, in 45 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

23 Oct 20268-K · 7.01, 8.01Nordson completed acquisition of Contrinex for ~$168M enterprise value, expanding industrial sensing and automation portfolio. Contrinex generates ~$50M annual revenue. Acquisition aligns with Nordson Ascend Strategy for top-tier growth.acquisitionopen

Figures in the filing · each found in the filing text

annual revenue · Contrinex$50M

Risks flagged

Integration risk of Contrinex into Nordson's operations and culture.

“Acquisition integration may pose operational and cultural challenges.”
Read the original on SEC EDGAR ↗
20 Aug 202610-QNordson reported Q3 FY2026 results with revenue +10.3% YoY, EPS +23% YoY, and strong ATS segment growth.earningsopen

Figures in the filing · each found in the filing text

Sales · Q3-2026$818M+10% y/y
Net income · Q3-2026$153M+22% y/y
Diluted earnings per share · Q3-2026$2.73+23% y/y
Gross margin % · Q3-202655.5%
Operating cash flow · 9M-2026$570M+11% y/y
Segment EBITDA - ATS · Advanced Technology Solutions · Q3-2026$66M+58% y/y
Segment EBITDA - IPS · Industrial Precision Solutions · Q3-2026$130M-0% y/y
Segment EBITDA - MFS · Medical and Fluid Solutions · Q3-2026$88M+6% y/y

Risks flagged

Unrealized loss on minority investment

“Unrealized loss of $14,892 for the three months ended July 31, 2026 was included in Other income (expense) - net.”

Foreign currency exposure

“Foreign currency losses of $2,023 for three months ended July 31, 2026.”
Read the original on SEC EDGAR ↗
19 Aug 20268-K · 2.02, 7.01Sales $818M (+10% y/y); Earnings per diluted share $2.73 (+23% y/y); Adjusted earnings per diluted share $3.25 (+19% y/y); Guidance: Sales guidance raised to $3,035-$3,075M; adjusted EPS to $11.80-$12.00earningsopen

Figures in the filing · each found in the filing text

Sales · Q3-2026$818M+10% y/y
Earnings per diluted share · Q3-2026$2.73+23% y/y
Adjusted earnings per diluted share · Q3-2026$3.25+19% y/y
EBITDA · Q3-2026$262M+10% y/y
Industrial Precision Solutions sales · Industrial Precision Solutions · Q3-2026$367M+5% y/y
Medical and Fluid Solutions sales · Medical and Fluid Solutions · Q3-2026$231M+5% y/y
Advanced Technology Solutions sales · Advanced Technology Solutions · Q3-2026$220M+28% y/y

Guidance

Sales guidance raised to $3,035-$3,075M; adjusted EPS to $11.80-$12.00

Full year guidance raised based on strong backlog (+35% YoY) and order entry momentum; all segments performing above expectations.

Read the original on SEC EDGAR ↗
3 Jun 20268-K · 2.03Took on a material direct financial obligation, increasing leverageopen

Risks flagged

Increased leverage and short-term debt exposure; potential refinancing risk if CP market tightens.

“maximum aggregate amount outstanding at any time of $1.2 billion” · word for word
Read the original on SEC EDGAR ↗
21 May 202610-QNordson reported Q2 FY2026 revenue of $740.8M (+8.5% YoY) and operating margin expansion of ~190bps, with all segments growing.earningsopen

Figures in the filing · each found in the filing text

Sales · Q2-2026$741M+9% y/y
Sales · H1-2026$1.41B+9% y/y
Net income · Q2-2026$117M+4% y/y
Net income · H1-2026$251M+21% y/y
Operating cash flow · H1-2026$321M+15% y/y
Free cash flow · H1-2026$293M+22% y/y
Segment EBITDA - IPS · Industrial Precision Solutions · Q2-2026$124M+9% y/y
Segment EBITDA - MFS · Medical and Fluid Solutions · Q2-2026$79M+4% y/y
Segment EBITDA - ATS · Advanced Technology Solutions · Q2-2026$48M+22% y/y
Diluted EPS · Q2-2026$2.09+6% y/y

Risks flagged

Pension settlement charge

“Pension settlement charge $24,049”

Derivative losses

“Foreign currency forward contracts loss $12,657 (Q2)”
Read the original on SEC EDGAR ↗
20 May 20268-K · 2.02, 7.01Sales $741M (+8% y/y); Earnings per diluted share $2.09 (+6% y/y); Adjusted earnings per diluted share $2.86 (+18% y/y); Guidance: FY sales guidance raised to $2.93-3.01B; FY adjusted EPS guidance raised to $11.30-11.80.earningsopen

Figures in the filing · each found in the filing text

Sales · Q2-2026$741M+8% y/y
Earnings per diluted share · Q2-2026$2.09+6% y/y
Adjusted earnings per diluted share · Q2-2026$2.86+18% y/y
EBITDA · Q2-2026$235M+8% y/y
Industrial Precision Solutions sales · Industrial Precision Solutions · Q2-2026$350M+10% y/y
Medical and Fluid Solutions sales · Medical and Fluid Solutions · Q2-2026$213M+5% y/y
Advanced Technology Solutions sales · Advanced Technology Solutions · Q2-2026$178M+10% y/y

Guidance

FY sales guidance raised to $2.93-3.01B; FY adjusted EPS guidance raised to $11.30-11.80.

Company raised full-year guidance citing robust order entry and backlog growth across all segments. Q3 guidance also provided with sales $760-790M and adj. EPS $2.95-3.15.

Risks flagged

One-time pension settlement charge and non-cash loss on minority investments impacted GAAP earnings.

“Second quarter 2026 earnings included a one-time, non-cash settlement charge to annuitize about 30% of the U.S. pension obligation and a non-cash loss on minority investments recognized during the quarter.” · word for word
Read the original on SEC EDGAR ↗
19 Feb 202610-QNordson reported strong Q1 FY2026 results with sales up 8.8% YoY, net income up 40.9%, and diluted EPS up 44.2%, driven by strong ATS segment growth and an unrealized gain on a minority investment.open

Figures in the filing · each found in the filing text

Sales · Q1-2026$669M+9% y/y
Net income · Q1-2026$133M+41% y/y
Diluted earnings per share · Q1-2026$2.38+44% y/y
Gross margin · Q1-202654.7%
Operating profit · Q1-2026$166M+18% y/y
Operating cash flow · Q1-2026$140M-12% y/y
IPS segment sales · Industrial Precision Solutions · Q1-2026$327M+9% y/y
MFS segment sales · Medical and Fluid Solutions · Q1-2026$193M-0% y/y
ATS segment sales · Advanced Technology Solutions · Q1-2026$149M+23% y/y
IPS segment EBITDA · Industrial Precision Solutions · Q1-2026$110M-2% y/y

Risks flagged

Tariff and Trade Policy Risk

“The impact of changes in trade policies, tariffs, and other import/export regulations of the United States and other nations could negatively impact our cash flow from operations and liquidity in future periods.” · word for word

Foreign Exchange Risk

“We are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled.” · word for word

Geopolitical Risk

“the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics.” · word for word
Read the original on SEC EDGAR ↗
18 Feb 20268-K · 2.02, 7.01Sales $669M (+9% y/y); Adjusted earnings per diluted share $2.37 (+15% y/y); EBITDA $203M (+8% y/y); Guidance: Full-year sales guidance raised to $2,860-$2,980M; adjusted EPS guidance raised to $11.00-$11.60.earningsopen

Figures in the filing · each found in the filing text

Sales · Q1-2026$669M+9% y/y
Adjusted earnings per diluted share · Q1-2026$2.37+15% y/y
EBITDA · Q1-2026$203M+8% y/y
Backlog growth · Q1-20264.0%

Guidance

Full-year sales guidance raised to $2,860-$2,980M; adjusted EPS guidance raised to $11.00-$11.60.

Strong Q1 beat and raised full-year guidance driven by broad-based demand, semiconductor recovery, and growing backlog.

Risks flagged

Exposure to semiconductor cyclicality, though currently positive.

“Advanced Technology Solutions segment driven by semiconductor recovery.”

Foreign exchange risk, as favorable currency impact noted.

“Favorable currency translation impact of 4% in Q1.”
Read the original on SEC EDGAR ↗
2 Feb 20268-K · 1.01, 2.03Nordson entered an amended and restated credit agreement with Wells Fargo and other lenders, increasing leverage capacity. No dollar amount stated; material financial obligation created.open

Risks flagged

Increased debt obligation may raise financial leverage.

“Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement.” · word for word
Read the original on SEC EDGAR ↗
16 Jan 2026DEF 14ANordson filed its definitive proxy statement for the 2026 Annual Meeting, disclosing executive compensation details, governance practices, and shareholder proposals.open

Figures in the filing · each found in the filing text

Sales · FY2025$2.80B+4% y/y
EBITDA · FY2025$900M
Operating Profit · FY2025$712M
Dividends Paid · FY2025$179M
Net Income · FY2025$484M
Free Cash Flow · FY2025$661M
Adjusted Earnings Per Share · FY2025$10.24
Gross Margin · FY202555.0%
Free Cash Flow Conversion · FY2025136.0%
Total Shareholder Return (10 Year) · FY2025226.0%
Read the original on SEC EDGAR ↗
17 Dec 202510-KSales $2.79B (+4% y/y); Net income $484M (+4% y/y); Operating cash flow $719Mopen

Figures in the filing · each found in the filing text

Sales · FY2025$2.79B+4% y/y
Net income · FY2025$484M+4% y/y
Operating cash flow · FY2025$719M
Free cash flow · FY2025$661M
IPS segment sales · Industrial Precision Solutions · FY2025$1.33B-5% y/y
MFS segment sales · Medical and Fluid Solutions · FY2025$835M+20% y/y
ATS segment sales · Advanced Technology Solutions · FY2025$625M+5% y/y
Americas sales · Americas · FY2025$1.21B+2% y/y
Europe sales · Europe · FY2025$722M-1% y/y
Asia Pacific sales · Asia Pacific · FY2025$864M+10% y/y

Risks flagged

Organic sales decline in IPS segment

“The IPS organic sales decrease of 5.1 percent was driven by declines in polymer processing and industrial coatings product lines.” · word for word

Tariff and trade policy exposure

“The impact of changes in trade policies, tariffs, and other import/export regulations of the United States and other nations could negatively impact our cash flow from operations and liquidity in future periods.” · word for word
Read the original on SEC EDGAR ↗
10 Dec 20258-K · 2.02, 7.01Sales $752M (+1% y/y); Earnings per diluted share $2.69; Adjusted earnings per diluted share $3.03 (+9% y/y); Guidance: FY2026 sales $2,830-2,950M, adjusted EPS $10.80-11.50earningsopen

Figures in the filing · each found in the filing text

Sales · Q4-2025$752M+1% y/y
Earnings per diluted share · Q4-2025$2.69
Adjusted earnings per diluted share · Q4-2025$3.03+9% y/y
Sales · FY2025$2.80B+4% y/y
Earnings per diluted share · FY2025$8.51
Adjusted earnings per diluted share · FY2025$10.24+5% y/y
EBITDA · Q4-2025$256M+6% y/y
EBITDA · FY2025$900M
Free cash flow · FY2025$661M
Backlog · FY2025$600M+5% y/y

Guidance

FY2026 sales $2,830-2,950M, adjusted EPS $10.80-11.50

FY2026 guidance implies continued growth with adjusted EPS up 5-12% from FY2025; backlog up 5% provides visibility.

Risks flagged

Organic sales decline in Q4 and full year, with weakness in polymer processing and test/inspection systems.

“organic sales decrease of 1% in Q4; 3% decrease in organic volume for full year.”

FY2026 guidance midpoint implies modest growth, with first quarter sales forecasted lower sequentially.

“FY2026 sales range $2,830-2,950M vs FY2025 $2.8B; Q1 FY2026 sales forecast $630-670M vs Q4 FY2025 $752M.”
Read the original on SEC EDGAR ↗
28 Oct 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportSEC ↗

Nordson Corporation — questions

What did Nordson Corporation file recently?
13 SEC filings in the last 12 months. Latest: 8-K on 2026-10-23 — Nordson completed acquisition of Contrinex for ~$168M enterprise value, expanding industrial sensing and automation portfolio. Contrinex generates ~$50M annual revenue. Acquisition aligns with Nordson Ascend Strategy for top-tier growth.

Every figure on this page comes from Nordson Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.